Tag: Sanofis
Sanofi’s announced sale of Doliprane raises many concerns
Sanofi will sell its subsidiary producing Doliprane no earlier than the last quarter of this year 2024. Thirteen production sites are concerned, including two in France. A financial operation estimated…
behind Sanofi’s “augmented biology” patch, many promises and little proof – L’Express
As the Olympic Games approach, a curious little piece of plastic has appeared on the bodies of athletes. A “painkiller” patch, to stick where it hurts. Called Initiv® and sold…
Sanofi’s massive investment in drug production – L’Express
As the Choose France summit begins, where several other foreign laboratories have announced a total of more than a billion euros in new investments in France, the French pharmaceutical group…
Medicines, vaccines… Sanofi’s new strategy – L’Express
The French pharmaceutical group is changing its strategy. Sanofi announced, Friday October 27, its intention to separate from its “Consumer Health” activity in 2024 to focus on innovative medicines and…